131 related articles for article (PubMed ID: 20048551)
1. Benign prostatic hyperplasia: does lifestyle play a role?
Barnard RJ; Aronson WJ
Phys Sportsmed; 2009 Dec; 37(4):141-6. PubMed ID: 20048551
[TBL] [Abstract][Full Text] [Related]
2. Review of exercise and the risk of benign prostatic hyperplasia.
Sea J; Poon KS; McVary KT
Phys Sportsmed; 2009 Dec; 37(4):75-83. PubMed ID: 20048544
[TBL] [Abstract][Full Text] [Related]
3. Clinical and experimental studies of benign prostatic hyperplasia.
Coffey DS; Walsh PC
Urol Clin North Am; 1990 Aug; 17(3):461-75. PubMed ID: 1695775
[TBL] [Abstract][Full Text] [Related]
4. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
5. The overlooked cause of benign prostatic hyperplasia: prostatic urethral angulation.
Cho KS; Kim J; Choi YD; Kim JH; Hong SJ
Med Hypotheses; 2008; 70(3):532-5. PubMed ID: 17761390
[TBL] [Abstract][Full Text] [Related]
6. Role of growth factors in benign prostatic hyperplasia.
Lawson RK
Eur Urol; 1997; 32 Suppl 1():22-7. PubMed ID: 9218939
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
8. Effect of diet and exercise intervention on the growth of prostate epithelial cells.
Barnard RJ; Kobayashi N; Aronson WJ
Prostate Cancer Prostatic Dis; 2008; 11(4):362-6. PubMed ID: 18283296
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factors and risk of benign prostatic hyperplasia.
Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
Prostate; 2002 Jul; 52(2):98-105. PubMed ID: 12111701
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
Undén AL; Elofsson S; Brismar K
Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
[TBL] [Abstract][Full Text] [Related]
11. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.
Parsons JK
J Urol; 2007 Aug; 178(2):395-401. PubMed ID: 17561143
[TBL] [Abstract][Full Text] [Related]
12. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study.
Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C
BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304
[TBL] [Abstract][Full Text] [Related]
13. Dietary patterns and surgically treated benign prostatic hyperplasia: a case control study in Western Australia.
Ambrosini GL; de Klerk NH; Mackerras D; Leavy J; Fritschi L
BJU Int; 2008 Apr; 101(7):853-60. PubMed ID: 18070188
[TBL] [Abstract][Full Text] [Related]
14. Pathology of benign prostatic hyperplasia.
Roehrborn CG
Int J Impot Res; 2008 Dec; 20 Suppl 3():S11-8. PubMed ID: 19002119
[TBL] [Abstract][Full Text] [Related]
15. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia.
Dahle SE; Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Hsing AW
J Urol; 2002 Aug; 168(2):599-604. PubMed ID: 12131317
[TBL] [Abstract][Full Text] [Related]
16. Lifestyle changes to prevent BPH: heart healthy = prostate healthy.
Moyad MA
Urol Nurs; 2003 Dec; 23(6):439-41. PubMed ID: 14725161
[TBL] [Abstract][Full Text] [Related]
17. New insights into the epidemiology and natural history of benign prostatic hyperplasia.
Boyle P
Prog Clin Biol Res; 1994; 386():3-18. PubMed ID: 7528398
[TBL] [Abstract][Full Text] [Related]
18. Putative role of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men.
Kehinde EO; Akanji AO; Mojiminiyi OA; Bashir AA; Daar AS; Varghese R
Prostate Cancer Prostatic Dis; 2005; 8(1):84-90. PubMed ID: 15775992
[TBL] [Abstract][Full Text] [Related]
19. Role of testosterone, estradiol, and insulin in diet- and exercise-induced reductions in serum-stimulated prostate cancer cell growth in vitro.
Tymchuk CN; Barnard RJ; Ngo TH; Aronson WJ
Nutr Cancer; 2002; 42(1):112-6. PubMed ID: 12235642
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
